Posted on 3 月 27, 20243/27/24
Growing EVERSANA’s Value & Evidence Global Footprint with the Additions of Monique Martin, Pamela Vo and Deepika Thakur
Posted on 3 月 1, 20243/1/24
Future-Proofing Demands Proof: How Innovators Are Transforming Pharma Commercialization
Posted on 2 月 26, 20242/26/24
Q&A: Enhanced Protection and Consistency for PRCI in Canada
Posted on 2 月 21, 20242/21/24
The Looming Legacy of Software as a Medical Device (SaMD) Misclassification Under Medical Device Directive (MDD)
Posted on 1 月 9, 20241/9/24
Impact of the European Union Medical Device Regulation Extension on Legacy Devices
Posted on 1 月 9, 20241/9/24
An Impactful Year for Global Regulation of Digital Health
Posted on 6 月 12, 20236/12/23
Informing Optimal Pricing Strategies with a Comprehensive Modeling Approach
Posted on 4 月 27, 20234/27/23
European Commission’s Long-awaited Pharma Legislation Review Gets Mixed Reception
Posted on 4 月 6, 20234/6/23